Potential U.S. Tariffs on Pharmaceuticals Expected to Have Minimal Impact on Alvotech’s Product ...
4 Articles
4 Articles
Potential U.S. Tariffs on Pharmaceuticals Expected to Have Minimal Impact on Alvotech’s Product ...
REYKJAVIK, Iceland, May 07, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO) (the “Company”) a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today issued a statement on the anticipated impact of potential tariffs…
Pipes: "Imposing tariffs on pharmaceutical products and ingredients would be a grave mistake" - Center for Medical Economics and Innovation
Read comments submitted to the U.S. Department of Commerce by Sally C. Pipes, PRI President, CEO, and Thomas W. Smith Fellow in Health Care Policy, arguing against the imposition of tariffs on pharmaceuticals as part of the Department’s examination of pharmaceutical imports and their relevance to U.S. national security interests. Click here to download a copy of Pipes’ comments Thank you for inviting public input on the Department’s Section 232 …
Alvotech estimates that potential tariffs on drug imports to the United States would have a negligible impact on the company's revenue from drug sales this year.
Coverage Details
Bias Distribution
- 50% of the sources are Center, 50% of the sources lean Right
To view factuality data please Upgrade to Premium